Accès gratuit
Med Sci (Paris)
Volume 23, Numéro 2, Février 2007
Page(s) 198 - 204
Section M/S revues
Publié en ligne 15 février 2007
  1. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 1996; 104 (suppl 4) : 715–40.
  2. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenœstrogens. Environ Health Perspect 1996; 104 (suppl 4) : 741–803.
  3. Jégou B, Auger J, Multigner L, et al. The saga of the sperm count decrease in humans and wild and farm animals. In : Gagnon C, ed. The male gamete : from basic sciences to clinical applications. Vienna, IL, USA : Cache River Press 1999 : 445–54.
  4. Eustache F, Auger J, Cabrol D, Jouannet P. Are volunteers delivering semen samples in fertility studies a biased population ? Hum Reprod 2004; 19 : 2831–7.
  5. Auger J, Kunstmann JM, Czyclik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995; 332 : 281–5.
  6. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113 : 1056–61.
  7. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16 : 972–8.
  8. Slama R, Bouyer J, Remontet L, Spira A. Epidemiology of male reproductive function: a field searching for tools. Rev Epidemiol Sante Publ 2004; 52 : 221–42.
  9. Jensen TK, Joffe M, Scheike T, et al. Time trends in waiting time to pregnancy among Danish twins. Hum Reprod 2005; 20 : 955–64.
  10. Boisen K, Chellakooty M, Schmidt I, et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at 3 months of age. J Clin Endocrinol Metab 2005; 90 : 4041–6.
  11. Cheek OA, Kow K, Chen J, McLachlan JA. Potential mechanisms of thyroid disruption in humans : interaction of organochlorine compounds with thyroid receptor, transthyretin and thyroid-binding globulin. Environ. Health Perspect 1999; 107 : 273–8.
  12. Arcaro KF, Yi L, Seegal RF, et al. 2,2’, 6, 6’-tetrachlorobiphenyl is œstrogenic in vitro and in vivo. J Cell Biochem 1999; 72 : 94–102.
  13. Kester MHA, Bulduk S, Tibboel D, et al. Potent inhibition of œstrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the œstrogenic activity of PCBs. Endocrinology 2000; 141 : 1897–1900.
  14. Mocarelli P, Gerthoux PM, Ferrari E, et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 2000; 355 : 1858–63.
  15. Meerts IA, Letcher RJ, Hoving S, et al. In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environ Health Perspect 2001; 109 : 399–407.
  16. Acevedo R, Parnell PG, Villanueva H, et al. The contribution of hepatic steroid metabolism to serum estradiol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency. J Appl Toxicol 2005; 25 : 339–53.
  17. Calafat AM, Kuklenyik Z, Reidy JA, et al. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113 : 391–5.
  18. Markey CM, Luque EH, Munoz de Toro MM, et al. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001; 65 : 1215–23.
  19. Timms BG, Howdeshell KL, Barton L, et al. Œstrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005; 102 : 7014–9.
  20. Zalko D, Soto AM, Dolo L, et al. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect 2003; 111 : 309–19.
  21. Saillenfait AM, Laudet-Lesbert A. Phtalates. EMC-Toxicologie-Pathologie, Elsevier Paris, France 2005; 2 : 1–13.
  22. Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl 2006; 29 : 140–7.
  23. Mahood IK, McKinnell C, Walker M, et al. Cellular origins of testicular dysgenesis in rats exposed in utero to di(n-butyl) phthalate. Int J Androl 2006; 29 : 148–54.
  24. Zacharewski TR, Meek MD, Clemons JH, et al. Examination of the in vitro and in œstrogenic activities of eight commercial phthalate esters. Toxicol Sci 1998; 46 : 282–93.
  25. Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000; 108 : 895–900.
  26. Taylor JR, Selhorst JB, Houff SA, Martinez AJ. Chlordecone in toxication in man. I. Clinical observations. Neurology 1978; 28 : 626–30.
  27. Shelby MD, Newbold RR, Tully DB, et al. Assessing environmental chemicals for œstrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 1996; 104 : 1296–300.
  28. Monosson E, Kelce WR, Lambright C, et al. Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male. Toxicol Ind Health 1999; 65–79.
  29. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308 : 1466–9.
  30. Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 1998; 217 : 386–92.
  31. Bennetau-Pelissero C, Latonnelle K, Séqueira A, Lamothe V. Phytœstrogens, endocrine disrupters from food. Analusis 2000; 28 : 763–75.
  32. Murphy PA, Song T, Buseman G, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem 1999; 47 : 2697–704.
  33. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytœstrogens in early life. Am J Clin Nutr 1998; 68 (suppl) : S1453–61.
  34. Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumoregenesis in female rat offspring. Oncol Rep 1999; 6 : 1089–95.
  35. Newbold RR, Padilla Banks E, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001; 61 : 4325–8.
  36. Drash AL, Kramer MS, Swanson J, Udall JN. Infant breeding practices and their possible relationship to the etiology of diabetes mellitus. Pediatrics 1994; 94 : 752–4.
  37. North K, Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. Br J Urol Int 2000; 85 : 107–13.
  38. Europa-environment. How the European commission uses the precautionary principle to tackle endocrine disrupters. Bruxelles : UE, 2005.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.